Northern Trust
GLSI icon

Northern Trust’s Greenwich LifeSciences GLSI Stock Holding History

Northern Trust’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Buy
75,125
+2,116
+3% +$55.2K ﹤0.01% 3026
2025
Q4 		$1.53M Sell
73,009
-2,896
-4% -$30.5K ﹤0.01% 3148
2025
Q3 		$755K Sell
75,905
-6,874
-8% -$77.6K ﹤0.01% 3515
2025
Q2 		$751K Sell
82,779
-1,854
-2% -$17.6K ﹤0.01% 3517
2025
Q1 		$807K Sell
84,633
-2,790
-3% -$33.8K ﹤0.01% 3371
2024
Q4 		$982K Buy
87,423
+12,923
+17% +$173K ﹤0.01% 3401
2024
Q3 		$1.07M Buy
74,500
+50,180
+206% +$744K ﹤0.01% 3333
2024
Q2 		$420K Buy
24,320
+3,105
+15% +$45.4K ﹤0.01% 3572
2024
Q1 		$423K Buy
21,215
+232
+1% +$2.86K ﹤0.01% 3616
2023
Q4 		$221K Buy
+20,983
New +$210K ﹤0.01% 3869
2022
Q2 		– Sell
-35,060
Closed -$688K – 4771
2022
Q1 		$688K Sell
35,060
-1,582
-4% -$32K ﹤0.01% 3603
2021
Q4 		$891K Buy
36,642
+132
+0.4% +$4.42K ﹤0.01% 3589
2021
Q3 		$1.43M Buy
36,510
+24,412
+202% +$1.02M ﹤0.01% 3422
2021
Q2 		$544K Buy
+12,098
New +$457K ﹤0.01% 3680

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust's GLSI Position: Q1 2026 in Review

Northern Trust increased its Greenwich LifeSciences (GLSI) stake by 2.9% in Q1 2026, buying an estimated $55.2K and bringing the position to 75,125 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3026.

Northern Trust first reported a position in GLSI in Q2 2021 and has held it in 14 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Northern Trust held 75,125 shares of Greenwich LifeSciences worth $1.8M as of Q1 2026.
  • Northern Trust bought 2,116 Greenwich LifeSciences shares in Q1 2026, an estimated $55.2K.
  • Greenwich LifeSciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3026 holding.
  • Northern Trust first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 14 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.